Mode
Text Size
Log in / Sign up

Retrospective study identifies CRP, pleural effusion, and LDH as risk factors for plastic bronchitis in children with refractory M. pneumoniae pneumoniaStudy identifies three risk factors for plastic bronchitis in children with severe pneumonia

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider CRP >20 mg/L, pleural effusion, and high LDH as potential risk markers for plastic bronchitis in children with refractory M. pneumoniae pneumonia.

A retrospective cohort study analyzed 205 hospitalized children diagnosed with refractory Mycoplasma pneumoniae pneumonia (RMPP) at two tertiary hospitals to identify risk factors for plastic bronchitis (PB). The study found that 52 patients (25.4% of the cohort) developed PB. Researchers developed a nomogram prediction model indicating three risk factors associated with PB development: C-reactive protein (CRP) levels > 20 mg/L, presence of pleural effusion, and high lactate dehydrogenase (LDH) levels.

The prediction model demonstrated an area under the receiver operating characteristic curve (AUC) of 0.783 (95% CI: 0.71–0.86), suggesting moderate discriminatory ability. The Hosmer–Lemeshow goodness-of-fit test showed a P-value of 0.408, indicating adequate model calibration. No specific intervention or exposure was reported, and the comparator group consisted of children with RMPP who did not develop PB.

Safety and tolerability data were not reported in this retrospective analysis. The study has several limitations: it was observational and retrospective in design, conducted at only two tertiary centers, and did not report follow-up duration. The model identifies statistical associations for risk prediction but does not establish causation or confirm PB diagnosis. Funding sources and conflicts of interest were not reported.

For clinical practice, these findings suggest that in children with RMPP, clinicians might consider monitoring CRP levels, checking for pleural effusion, and assessing LDH levels as potential indicators of increased PB risk. However, given the observational nature and moderate predictive performance of the model, these factors should not replace clinical judgment or definitive diagnostic procedures like bronchoscopy when indicated.

Researchers looked back at the medical records of 205 children who were hospitalized with a severe type of pneumonia called refractory Mycoplasma pneumoniae pneumonia (RMPP). They wanted to understand which children were more likely to develop a serious complication called plastic bronchitis (PB), where rubbery material forms in the airways. The study was conducted at two large hospitals.

They found that about 25% of the children in the study (52 out of 205) developed plastic bronchitis. By analyzing the children's data, the researchers created a prediction model. This model pointed to three factors linked to a higher chance of developing PB: a blood marker called C-reactive protein (CRP) being above 20 mg/L, having fluid around the lung (pleural effusion), and having high levels of another blood enzyme called LDH.

It is important to be careful with these results. This was a retrospective study, meaning it looked at past records. This type of study can show links or associations, but it cannot prove that these factors cause plastic bronchitis. The prediction model performed reasonably well in this specific group of patients, but it needs to be tested in other groups of children to see if it holds up. The study did not report on specific safety concerns or side effects. For now, this research helps doctors know what signs to watch for in children with severe pneumonia, but more studies are needed.

What this means for you:
A study linked three markers to higher risk of a lung complication in kids with severe pneumonia, but more research is needed.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedMar 2026
View Original Abstract ↓
ObjectiveTo determine the risk factors for plastic bronchitis (PB) in children diagnosed with Mycoplasma Pneumoniae Pneumonia (RMPP) and facilitate early intervention.MethodsA retrospective study of 205 hospitalized children diagnosed with RMPP in two tertiary hospitals was conducted from January 2023 to May 2025. The children were divided into the PB group and non-PB group. Clinical characteristics, laboratory indices, pulmonary imaging findings, and treatment approaches were compared between the two groups. A nomogram model was established based on logistic regression to assess the risk of PB in children infected with RMPP.ResultsA total of 52 patients (25.4%) were included in the PB group. The nomogram model constructed in this study indicated that three risk factors- C-reactive protein (CRP) > 20 mg/L, pleural effusion, and high Lactate Dehydrogenase (LDH) levels- could be used for the early identification of PB in children with RMPP. The area under the receiver operating characteristic curve of the prediction model was 0.783 (95%CI: 0.71–0.86). The Hosmer–Lemeshow goodness-of-fit test demonstrated the good calibration of the nomogram [(P = 0.408, R2 = 8.269)]. Decision curve analysis showed that the model had clinical value.ConclusionsEarly identification of these risk factors (CRP > 20 mg/L, pleural effusion, and elevated LDH) may facilitate timely bronchoscopic examination in children with RMPP at high risk of PB, potentially contributing to improved clinical management.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.